Emerald Health Therapeutics, Inc. (EMHTF)

0.2027 +0.0001 (+0.05%) At close: 3:55PM EDT

Emerald Health Therapeutics, Inc.

800 West Pender Street
Suite 210
Vancouver, BC V6C 1J8
Canada
800 757 3536
http://emeraldhealth.ca

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 161

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Avtar S. Dhillon	Exec. Chairman	387.44k	N/A	1962
Mr. Riaz Bandali M.B.A.	CEO & Pres	342.04k	N/A	1970
Ms. Jenn Hepburn B.B.A.	CFO & Company Sec.	761.08k	N/A	N/A
Mr. Orville Bovenschen	Sr. VP of Operations	N/A	N/A	N/A
Mr. Bernie Hertel	VP of Fin. and Communications	N/A	N/A	N/A
Ms. Rebecca Wong	Sr. VP of Quality & Regulatory Affairs	N/A	N/A	N/A

Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

Corporate Governance

Emerald Health Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.